At a glance
- Acetyl hexapeptide-8, sold as Argireline, is a synthetic six-amino-acid peptide modeled on part of the nerve protein SNAP-25 1.
- Cosmetic ingredients other than color additives need no FDA approval before sale, and it is not approved as a drug in the United States 2,3.
- Studied in people for crow's feet wrinkles, and in one small study for scars 4,1.
- Applied to the skin in creams and lotions 1. JumpstartMD does not prescribe it.
What is acetyl hexapeptide-8?
Acetyl hexapeptide-8 is a synthetic peptide, a short chain of six amino acids made in a laboratory 3. It is sold under the trade name Argireline, and was once listed as acetyl hexapeptide-3 1,3. Its sequence copies one end of SNAP-25, a protein that nerve endings use to release the signal that makes a muscle contract 1. In cosmetics it is listed as a skin conditioning agent and appears mostly in leave-on products 3.
Is acetyl hexapeptide-8 FDA-approved?
No, and no cosmetic ingredient other than color additives is. FDA's page on cosmetics, current as of November 18, 2025, says that "cosmetic products and ingredients do not need FDA premarket approval, with the exception of color additives" 2. FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act and can act against products on the market that break it 2. The companies that make or sell a cosmetic carry the legal responsibility for its safety 2. Since the Modernization of Cosmetics Regulation Act of 2022, "FDA has the authority to order a mandatory recall if the responsible person refuses to do so voluntarily" 5.
Whether a product is a cosmetic or a drug turns on its intended use, which FDA reads from its claims, its reputation and its ingredients 6. An article "intended to affect the structure or any function of the body" is a drug 6.
FDA's page on anti-aging products, current as of February 25, 2022, says that "if a product is intended, for example, to remove wrinkles or increase the skin's production of collagen, it's a drug or a medical device" 7. If a product is intended "to make lines and wrinkles less noticeable, simply by moisturizing the skin, it's a cosmetic" 7. In December 2020 the Cosmetic Ingredient Review's panel wrote that it "is not currently approved for drug use in the US" 3. So a cream carrying it reaches you with no FDA review of its safety or effectiveness before sale 2.
See the FDA status of every peptide, updated weekly.
How does acetyl hexapeptide-8 work?
The proposed mechanism is botulinum toxin's 1. Shown with purified proteins: the peptide blocked assembly of the SNARE complex, the machinery that lets nerve endings release acetylcholine 3. Less acetylcholine would mean weaker contraction of the small facial muscles that fold skin into expression lines 1. For a cream, that remains a hypothesis. In one laboratory test on human skin, most of the peptide was washed off and none was detected in the dermis 3. The 2025 review concluded that reaching muscle through intact skin "is likely impossible," and that any visible effect probably arises in the epidermis and upper dermis 1.
What does the research show?
Studied in people: one randomized, placebo-controlled trial in China enrolled 60 people, who applied the peptide or a placebo to crow's feet twice daily for four weeks 4. The authors report that "total anti-wrinkle efficacy in the argireline group was 48.9 %, compared with 0 % in the placebo group," a measure the abstract does not define 4. Measured skin roughness fell in the treated group 4.
The 2025 review names smaller studies 1. In a 2002 study, ten women had shallower wrinkles on silicone skin prints after 30 days, and small trials found no significant change in skin elasticity or hydration 1,3. The published wrinkle trials used 10 percent creams, while cosmetic makers reported using no more than 0.005 percent in 2019 1,3. No published data were found on how much enters the body, or on long-term toxicity 3.
What are the side effects?
In the Cosmetic Ingredient Review's record, a 0.05 percent solution caused no skin sensitization in a 50-person patch test 3. In a two-month study of eight people, the four who used the peptide cream reported no warmth, stinging, redness, itching or eye irritation 3. In a 24-person randomized trial in people with eyelid spasms, two treated and two placebo patients had minor, self-limiting eyelid irritation 3. In cells, high concentrations slowed the growth of human skin fibroblasts, and that study's authors called very high or very long use "potentially dangerous" 3.
One case report describes a Mycobacterium abscessus infection after the peptide was injected into the face, a use no cream is made for 1. In December 2020 the panel concluded that it is safe in cosmetics "at concentrations up to 0.005%," with the data "insufficient" to judge safety above that 3.
In sport
Acetyl hexapeptide-8 is not named on the 2026 Prohibited List of WADA, the World Anti-Doping Agency 8.
What JumpstartMD offers
JumpstartMD does not prescribe acetyl hexapeptide-8. Our peptide library covers it so you have the facts on its FDA status and the evidence, current as of November 9, 2026.
Book FREE Consultation
Share your details and a JumpstartMD team member will reach out shortly. Or call 408.478.3496 for your free, no-obligation consultation.
Share your details and a JumpstartMD team member will reach out when we open.
Disclaimer
Compounded medications are not FDA-approved, and FDA does not review their safety, effectiveness, or quality before they are marketed. A licensed clinician decides after an evaluation whether a peptide is appropriate for you, and not every patient will qualify.
Frequently Asked Questions
Is Argireline the same as Botox?
References
- J. Zdrada-Nowak, A. Surgiel-Gemza, and M. Szatkowska, "Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy," International journal of molecular sciences, vol. 26, no. 12, Jun. 2025, doi: 10.3390/ijms26125722. [Accessed: Nov. 9, 2026]. ↩
- U.S. Food and Drug Administration, "FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved." [Online]. Available: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated (accessed Nov. 9, 2026). ↩
- Cosmetic Ingredient Review, "Safety Assessment of Acetyl Hexapeptide-8 Amide as Used in Cosmetics," Revised Tentative Report for Public Comment, released Dec. 16, 2020. [Online]. Available: https://www.cir-safety.org/sites/default/files/acetyl122020revTR.pdf (accessed Nov. 9, 2026). ↩
- Y. Wang, M. Wang, S. Xiao, P. Pan, P. Li, and J. Huo, "The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects," American Journal of Clinical Dermatology, vol. 14, no. 2, pp. 147-153, Apr. 2013, doi: 10.1007/s40257-013-0009-9. [Accessed: Nov. 9, 2026]. ↩
- U.S. Food and Drug Administration, "Modernization of Cosmetics Regulation Act of 2022 (MoCRA)." [Online]. Available: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra [Accessed: Nov. 9, 2026]. ↩
- U.S. Food and Drug Administration, "Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)." [Online]. Available: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap (accessed Nov. 9, 2026). ↩
- U.S. Food and Drug Administration, "Wrinkle Treatments and Other Anti-aging Products." [Online]. Available: https://www.fda.gov/cosmetics/cosmetic-products/wrinkle-treatments-and-other-anti-aging-products [Accessed: Nov. 9, 2026]. ↩
- World Anti-Doping Agency, "The 2026 Prohibited List, International Standard," effective Jan. 1, 2026. [Online]. Available: https://www.wada-ama.org/en/prohibited-list [Accessed: Nov. 8, 2026]. ↩